These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 16027734
1. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Gapuzan ME, Schmah O, Pollock AD, Hoffmann A, Gilmore TD. Oncogene; 2005 Sep 29; 24(43):6574-83. PubMed ID: 16027734 [Abstract] [Full Text] [Related]
2. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype. Gapuzan ME, Yufit PV, Gilmore TD. Oncogene; 2002 Apr 11; 21(16):2484-92. PubMed ID: 11971183 [Abstract] [Full Text] [Related]
3. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Hanson JL, Hawke NA, Kashatus D, Baldwin AS. Cancer Res; 2004 Oct 15; 64(20):7248-55. PubMed ID: 15492243 [Abstract] [Full Text] [Related]
4. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW, Liang P. Oncogene; 2000 Feb 17; 19(7):841-9. PubMed ID: 10702792 [Abstract] [Full Text] [Related]
5. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Wang W, Abbruzzese JL, Evans DB, Larry L, Cleary KR, Chiao PJ. Clin Cancer Res; 1999 Jan 17; 5(1):119-27. PubMed ID: 9918209 [Abstract] [Full Text] [Related]
6. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity. Kaler P, Sasazuki T, Shirasawa S, Augenlicht L, Klampfer L. Exp Cell Res; 2008 Apr 15; 314(7):1507-18. PubMed ID: 18314102 [Abstract] [Full Text] [Related]
7. Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development. van Hogerlinden M, Auer G, Toftgård R. Oncogene; 2002 Jul 25; 21(32):4969-77. PubMed ID: 12118375 [Abstract] [Full Text] [Related]
8. Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-kappaB/rel complexes. Huang YH, Wu JY, Zhang Y, Wu MX. Oncogene; 2002 Oct 03; 21(44):6819-28. PubMed ID: 12360408 [Abstract] [Full Text] [Related]
9. Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts. Zhang HG, Huang N, Liu D, Bilbao L, Zhang X, Yang P, Zhou T, Curiel DT, Mountz JD. Arthritis Rheum; 2000 May 03; 43(5):1094-105. PubMed ID: 10817564 [Abstract] [Full Text] [Related]
10. Role of NF-kappaB in p53-mediated programmed cell death. Ryan KM, Ernst MK, Rice NR, Vousden KH. Nature; 2000 Apr 20; 404(6780):892-7. PubMed ID: 10786798 [Abstract] [Full Text] [Related]
11. The nuclear factor-kappaB and p53 pathways function independently in primary cells and transformed fibroblasts responding to genotoxic damage. Nesic D, Grumont R, Gerondakis S. Mol Cancer Res; 2008 Jul 20; 6(7):1193-203. PubMed ID: 18583526 [Abstract] [Full Text] [Related]
12. The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Gugasyan R, Voss A, Varigos G, Thomas T, Grumont RJ, Kaur P, Grigoriadis G, Gerondakis S. Mol Cell Biol; 2004 Jul 20; 24(13):5733-45. PubMed ID: 15199130 [Abstract] [Full Text] [Related]
13. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes. Gloushankova N, Ossovskaya V, Vasiliev J, Chumakov P, Kopnin B. Oncogene; 1997 Dec 11; 15(24):2985-9. PubMed ID: 9416842 [Abstract] [Full Text] [Related]
14. NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. Kwon O, Kim KA, Kim SO, Ha R, Oh WK, Kim MS, Kim HS, Kim GD, Kim JW, Jung M, Kim CH, Ahn JS, Kim BY. Carcinogenesis; 2006 Nov 11; 27(11):2258-68. PubMed ID: 16774937 [Abstract] [Full Text] [Related]
15. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Cavin LG, Wang F, Factor VM, Kaur S, Venkatraman M, Thorgeirsson SS, Arsura M. Mol Cancer Res; 2005 Jul 11; 3(7):403-12. PubMed ID: 16046551 [Abstract] [Full Text] [Related]
16. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Fehrenbacher N, Gyrd-Hansen M, Poulsen B, Felbor U, Kallunki T, Boes M, Weber E, Leist M, Jäättelä M. Cancer Res; 2004 Aug 01; 64(15):5301-10. PubMed ID: 15289336 [Abstract] [Full Text] [Related]
17. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. Butcher HL, Kennette WA, Collins O, Zalups RK, Koropatnick J. J Pharmacol Exp Ther; 2004 Aug 01; 310(2):589-98. PubMed ID: 15039454 [Abstract] [Full Text] [Related]
18. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells. Ishige K, Tanaka M, Arakawa M, Saito H, Ito Y. Neurochem Int; 2005 Dec 01; 47(8):545-55. PubMed ID: 16183169 [Abstract] [Full Text] [Related]
19. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. J Clin Invest; 2004 Aug 01; 114(4):569-81. PubMed ID: 15314694 [Abstract] [Full Text] [Related]
20. Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta. Jiang Y, Cui L, Yie TA, Rom WN, Cheng H, Tchou-Wong KM. Oncogene; 2001 Apr 26; 20(18):2254-63. PubMed ID: 11402320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]